Felgner
Jurgen Felgner, Augsburg DE
Patent application number | Description | Published |
---|---|---|
20080276801 | Device and Method for Purifying a Process Gas in a Reflow Soldering System - Disclosed is a device for purifying a process gas in a reflow soldering system. Said device comprises a receptacle that contains at least one packing bed. The process gas is fed to the receptacle via a gas inlet while being discharged from the receptacle after penetrating the packing bed. The inventive device further comprises an apparatus for delivering a liquid fluid to the receptacle. Secondary materials of the soldering process in the reflow soldering system can be absorbed by the liquid fluid and thus be eliminated from the process gas. Secondary materials and/or droplets and vapors of the fluid can additionally be absorbed and adsorbed on the surface of the packing. | 11-13-2008 |
Philip Felgner, Rancho Santa Fe, CA US
Patent application number | Description | Published |
---|---|---|
20080260763 | High Throughput Proteomics - Methods to obtain expression systems and proteins in a high-throughput protocol by utilizing mixtures of cells cultured from those transformed with a desired nucleotide sequence permit rapid production of protein for use in arrays to assess activity. In one embodiment, the proteins (or peptides) in the array are assessed for their immunological activity with regard to an infectious agent. | 10-23-2008 |
20100119535 | COMPOSITIONS AND METHODS FOR IMMUNODOMINANT ANTIGENS - Contemplated compositions, devices, and methods comprise immunodominant antigens from selected human pathogens ( | 05-13-2010 |
20140004141 | Methods And Compositions Of Protein Antigens For The Diagnosis And Treatment Of Toxoplasma Gondii Infections And Toxoplasmosis | 01-02-2014 |
20150037367 | Methods and Compositions Of Protein Antigens For The Diagnosis And Treatment of Herpes Simplex Viruses Type 1 and 2 - Contemplated compositions, devices, and methods are drawn to various antigens from Herpes Simplex Virus type 1 (HSV-1) and Herpes Simplex Virus type 2 (HSV-2) and their use in vaccines, therapeutic agents, and various diagnostic tests. In particularly preferred aspects, the antigens are immunodominant and have quantified and known relative reactivities with respect to sera of a population infected with the pathogen, and/or have a known association with a disease parameter. | 02-05-2015 |
Philip Felgner, Rancho Sante Fe, CA US
Patent application number | Description | Published |
---|---|---|
20090054255 | MICROFLUIDIC DEVICES AND METHODS - Contemplated microfluidic devices and methods are drawn to protein arrays in which distinct and detergent-containing antigen preparations are deposited onto an optical contrast layer in a non-specific and non-covalent manner. Detection of binding a is carried out using a dye that precipitates or agglomerates to so form a visually detectable signal at a dynamic range of at least three orders of magnitude. | 02-26-2009 |
20090285847 | Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis - Contemplated compositions, devices, and methods are drawn to various antigens from the pathogen | 11-19-2009 |
20110245099 | Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis - Contemplated compositions, devices, and methods are drawn to various antigens from the pathogen | 10-06-2011 |
20120142555 | Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis - Contemplated compositions, devices, and methods are drawn to various antigens from the pathogen | 06-07-2012 |
20120149600 | MICROFLUIDIC DEVICES AND METHODS - Contemplated microfluidic devices and methods are drawn to protein arrays in which distinct and detergent-containing antigen preparations are deposited onto an optical contrast layer in a non-specific and non-covalent manner. Detection of binding a is carried out using a dye that precipitates or agglomerates to so form a visually detectable signal at a dynamic range of at least three orders of magnitude. | 06-14-2012 |
20130072398 | Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis - Contemplated compositions, devices, and methods are drawn to various antigens from the pathogen | 03-21-2013 |
20150056241 | Compositions And Methods For Immunodominant Antigens - Contemplated compositions, devices, and methods comprise immunodominant antigens from selected human pathogens ( | 02-26-2015 |
Philip L. Felgner, Rancho Santa Fe, CA US
Patent application number | Description | Published |
---|---|---|
20100278866 | BORRELIA DIAGNOSTICS AND SCREENING METHODS - Compositions and methods of detecting | 11-04-2010 |
20130210651 | Borrelia Diagnostics and Screening Methods - The present invention provides methods of detecting | 08-15-2013 |
20140348870 | IMMUNOGENIC PLASMODIUM FALCIPARUM ANTIGEN COMPOSITIONS AND USES THEREOF - Contemplated compositions and methods employ selected antigens form | 11-27-2014 |
Phillip L. Felgner, Rancho Santa Fe, CA US
Patent application number | Description | Published |
---|---|---|
20120244178 | Plasmodium falciparum antigens - The invention relates to antigens, associated with sterile immunity, and methods of their use, in an immunogenic formulation to confer an immune response against | 09-27-2012 |
20150079126 | Plasmodium falciparum antigens - The invention relates to antigens, associated with sterile immunity, and methods of their use, in an immunogenic formulation to confer an immune response against | 03-19-2015 |